Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada

TORONTO, May 28, 2025 (GLOBE NEWSWIRE) — Brain Cancer Canada is proud to award $85,000 to a groundbreaking research project led by Dr. Sheila Singh and her team at McMaster University. The project titled “Lamin B Receptor (LBR) as an Immunotherapeutic Target for Recurrent Medulloblastoma,” aims to develop a highly specific and innovative treatment approach […]

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. – HUM

(NYSE:HUM), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Humana and certain of its officers and/or directors have engaged

Xcel Brands, Inc. Announces Fourth Quarter and Year-End 2024 Financial Results, Shows Improvements as a Result of Its “Project Fundamentals” Restructuring Program

(NASDAQ:XELB), Fourth quarter 2024 net loss of $7.1 million, compared with a net loss of $6.8 million for the prior year quarter. Net loss on a non-GAAP basis was $1.6 million for the fourth quarter 2024, representing a 53% improvement from the fourth quarter of 2023 non-GAAP net loss of $3.5 million. Net loss on

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. – GOCO

(NASDAQ:GOCO), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GoHealth and certain of its officers and/or directors have engaged

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Senti Biosciences, Inc. – SNTI

(NASDAQ:SNTI), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Senti Biosciences, Inc. (“Senti” or the “Company”) (NASDAQ: SNTI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Senti and certain of its officers and/or directors have

AI-Powered Defense at the Edge: Check Point Launches New Branch Office Security Gateways with 4x Faster Threat Prevention Performance

(NASDAQ:CHKP), REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) — Check Point(R) Software Technologies Ltd. (NASDAQ: CHKP), a pioneer and global leader of cyber security solutions, today announced major advancements to its family of Quantum Force Security Gateways. All Quantum Force Security Gateways for the data center and perimeter are receiving a 15%-25% performance boost

The United States Hispanic Business Council (USHBC) Announces the Appointment of April Diez, CEO of The Diez Group, to its Board of Directors.

WASHINGTON, May 28, 2025 (GLOBE NEWSWIRE) — The USHBC recently announced the appointment of April Diez, CEO of The Diez Group, to its Board of Directors. The Diez Group services multiple industries including automotive, specializing in metals processing, with precision-level blanking, cut-to-length lines, laser welding systems, milling, wash and oil capabilities, warehousing and logistics centers.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of T-Mobile US, Inc. – TMUS

(NASDAQ:TMUS), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of T-Mobile US, Inc. (“T-Mobile” or the “Company”) (NASDAQ: TMUS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether T-Mobile and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. – ICUI

(NASDAQ:ICUI), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU” or the “Company”) (NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ICU and certain of its officers and/or directors have

Ocusell Partners with Restb.ai to Enhance FMLS Listings with Built-In AI

IRVINE, Calif., May 28, 2025 (GLOBE NEWSWIRE) — Ocusell, a leading proptech innovator, today announced a strategic partnership with Restb.ai, the real estate industry's leader in AI-powered computer vision technology. This collaboration integrates Restb.ai advanced AI directly into Ocusell List, revolutionizing the listing management process for real estate professionals – with FMLS, the fourth largest

Scroll to Top